Company Monitoring Page for Takeda

latest headlines for company on cafepharma

Takeda pares down products and jobs, revives Genzyme building plans
Bizjournals
Fri, 10/18/19 - 09:50 am
Tags:
Takeda, Shire, M&A, layoffs
Debt-laden Takeda to sell OTC drugs in Middle East and Africa for $200m
Pharmaforum
Tue, 10/15/19 - 09:49 am
Tags:
Takeda, Shire, M&A, Acino, Middle East, Africa
ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech
Pharmaforum
Mon, 10/14/19 - 09:50 am
Tags:
ImaginAb, tumor imaging, AstraZeneca, Pfizer, Takeda
Takeda breaks into top 20 largest pharmas with Shire merger
Pharmaforum
Wed, 10/9/19 - 10:41 am
Tags:
Takeda, Shire, M&A
Goldfinch Bio, Takeda sign deal for CB1 monoclonal antibody to treat rare and metabolic kidney diseases
Pharmaceutical Business Review
Fri, 10/4/19 - 10:59 pm
Tags:
Goldfinch Bio, Takeda, CB1 monoclonal antibodies
Takeda pens Prometheus pact to find novel IBD targets
Fierce Biotech
Fri, 10/4/19 - 10:30 am
Tags:
Takeda, inflammatory bowel disease, R&D, Promethera Biosciences
Mom approved: J&J, Takeda and more lead Working Mother's best places to work list for 2019
Fierce Pharma
Wed, 10/2/19 - 10:53 am
Tags:
JNJ, Takeda, parents, Eli Lilly, Merck, Novo Nordisk, Sanofi
Takeda eyes emerging markets asset sale to trim its debt; report
Pharmaforum
Thu, 09/26/19 - 10:45 am
Tags:
Takeda, Shire, M&A, emerging markets, Europe
Takeda recalls Natpara but warns patients not to abruptly stop treatment
Fierce Pharma
Fri, 09/6/19 - 08:59 pm
Tags:
Takeda, Natpara, product recalls, drug manufacturing
Hospitals rationing immune disorder drug
Beckers Hospital Review
Fri, 08/9/19 - 07:37 pm
Tags:
Human Immune Globulin Infusion, drug shortages, Pfizer, Takeda
Takeda, Sosei form gastrointestinal disease R&D pact
Fierce Biotech
Mon, 08/5/19 - 10:43 am
Tags:
Takeda, Sosei Heptares, R&D, gastrointestinal disease
Takeda staffers accuse drugmaker of favoring Shire employees during merger: report
Fierce Pharma
Fri, 08/2/19 - 12:31 pm
Tags:
Korea, Shire, Takeda, employees, M&A
Drugmakers will profit from climate change, Morgan Stanley says
Beckers Hospital Review
Sun, 07/28/19 - 11:41 pm
Tags:
climate change, Morgan Stanley, Merck, Sanofi, vaccines, GSK, Takeda, JNJ, Moderna Therapeutics
As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization
Endpoints
Wed, 07/24/19 - 10:39 am
Tags:
Takeda, Shire, R&D, restructuring, M&A
Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt
BioSpace
Thu, 07/18/19 - 11:39 am
Tags:
Takeda, Shire, M&A
Takeda Receives 1st Stem Cell-Derived CAR-T From Kyoto University Collaboration
BioSpace
Tue, 07/16/19 - 12:02 pm
Tags:
Takeda, Kyoto University, CAR-T, stem cells
Novartis wraps up acquisition of Takeda’s dry eye drug Xiidra
Pharmaceutical Business Review
Tue, 07/2/19 - 10:24 am
Tags:
Novartis, Takeda, Xiidra, hdry eye disease
Takeda suffers another setback in its quest to expand myeloma drug’s reach — and blockbuster potential
Endpoints
Thu, 06/6/19 - 12:08 pm
Tags:
Takeda, Ninlaro, clinical trials
FDA approves GATTEX for children with short bowel syndrome
Pharmaceutical Business Review
Mon, 05/20/19 - 10:13 am
Tags:
Takeda, FDA, Gattex, short bowel syndrome, pediatrics
May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven
BioCentury
Wed, 05/15/19 - 11:52 pm
Tags:
Iovance, LN-145, cervical cancer, Takeda, TAK-788, non-small cell lung cancer, Amgen, AMG-510, Macrogenics, margetuximab, HER2-positive metastatic breast cancer, Forty Seven

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.